Zhao, D <br/><br/>
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.  [electronic resource] 

 -  Oncogene  Jun 2015 
 - 3107-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2014.257  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Proliferation--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>MCF-7 Cells<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplastic Stem Cells--drug effects<br/>Protein Binding--drug effects<br/>Proto-Oncogene Proteins c-myc--genetics<br/>SOXB1 Transcription Factors--genetics<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Tumor Cells, Cultured<br/>Up-Regulation--drug effects<br/>Vascular Endothelial Growth Factor A--pharmacology<br/>Vascular Endothelial Growth Factor Receptor-2--metabolism